We show that G2A-deficiency results in reduced mechanical hypersensitivity in vivo and leads to a markedly reduced number of immune cells and inflammatory mediators at the site of nerve injury, indicating a pivotal role of the G2A receptor in the initiation and progression of nerve injury-induced neuropathic pain. This evidence concerns the gene GPR132 and injury.